Related Experiment Video
Updated: Jan 4, 2026
12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.9K
Tissue Site and the Cancer Immunity Cycle
Brendan L Horton1, Tim B Fessenden1, Stefani Spranger2
1Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.
Trends in Cancer
|November 11, 2019
Summary
Checkpoint blockade immunotherapy (CBT) shows varied effectiveness across tumor sites. Understanding tissue-specific immune cells is key to improving cancer immunotherapy response rates.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Checkpoint blockade immunotherapy (CBT) has transformed cancer treatment.
- Factors influencing differential responsiveness to CBT across tumor sites are not well understood.
- Tissue-resident immune cells may impact immunotherapy efficacy.
Purpose of the Study:
- To review clinical and preclinical data on tissue-specific immune responses in cancer.
- To explore how these responses affect the tumor immune microenvironment.
- To elucidate how tissue-specific immunity influences immunotherapy efficacy.
Main Methods:
- Literature review of clinical and preclinical investigations.
- Analysis of studies examining immune cell composition in different tissue sites.
- Synthesis of data on the tumor immune microenvironment and immunotherapy response.
Main Results:
- Tumor site-specific immune cell populations (lymphoid and myeloid) differ.
- These differences can influence tumor susceptibility to immunotherapy.
- Interplay between local and systemic immunity is critical for treatment outcomes.
Conclusions:
- Tissue-specific immune microenvironments significantly impact checkpoint blockade immunotherapy efficacy.
- Targeting tissue-resident immune cells may enhance cancer immunotherapy.
- Further research into immune cell interplay is needed to optimize cancer treatment strategies.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:40Cell-mediated Immune Responses
83.2K
Overview
83.2K
02:12What is Cancer?
13.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.8K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
02:30Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K